The Karnataka Innovation and Technology Society (KITS) of Department of Information Technology and Biotechnology, Government of Karnataka, has led a delegation to Philadelphia, Pennsylvania to participate in BIO 2019, one of the largest biotechnology expos in the world. The event which was held from June 3 to 6, 2019 had representations including six bio-start-ups under capacity building through exposure visits and workshops of the Karnataka Start-up Policy.
The US convention held in June annually has been an important platform for the Department of IT, BT and S&T to showcase the state’s biotechnology ecosystem and learn more about the global perspectives. “Since 2013, we have been participating through the Biotechnology Facilitation Cell (BFC) along the Vision Group for BT, biotech companies, and researchers from top institutes across India,” said Dr. S Balasubramanya, Sr. Consultant (Biotech), KITS, Karnataka Dept. of IT, BT & S&T.
The six bio-start-ups that were partially financed by KITS for participation in BIO 2019 include Sensivision, Health Technologies, Mocxa Health, Retisense, Atrimed Biotech, Viable Near Infra Red (VNIR) Biotechnologies and Denovo Biolabs.
“The event had around 16,000 delegates from over 74 countries. The agenda over three days were sessions on business partnering, education, networking, and an exhibition showcasing the advancements in the biotech sector. Further, the event was envisaged as an ideal platform for start-ups to seeks funding and tap potential buyers, besides facilitated interactions and exchange ideas,” said Dr. Jitendra Kumar, managing director, Bangalore Bioinnovation Centre.
Mocxa Health is an innovation-driven startup developing solutions for the diagnosis of seizures, epilepsy, sleep disorders and movement disorders. The startups uses programmable cameras, video & image processing, computer vision and robotics to create superior diagnostic products.
Atrimed Biotech is working on novel small molecule therapeutics for chronic inflammation driven skin diseases, pain management and cancer.
Viable Near Infra Red (VNIR) Biotechnologies has its core strengths in molecular probe technologies” to develop new paradigms in disease diagnostics.
Denovo Biolabs is specialized in product development of quality Immunological tools.
Among the independent companies from Karnataka for the event were Anthem Biosciences, Aurigene Discovery Technologies, Bangalore Bioinnovation Centre, Eurofins Advinus, Richcore Lifesciences, Stelis Biopharma, and Syngene International.